Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2309)	10/14/1997 10:53:00 AM
From: biodoc	of 6136

What was the patient population in the 141W94 + 3TC + AZT trial? Were these early patients naive to therapy, or had they been pre-treated with AZT or AZT + 3TC? I did not find the characteristics of the patient population in the press release. If the population was either late or pre-treated, the results may not be so bad.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next